(Q45166008)

10 December 2017

Longitudinal changes in functional disability in Alzheimer's disease patients (English)

1 reference

10 December 2017

0 references

0 references

H Michael Arrighi

1

1 reference

10 December 2017

Isabelle Gélinas

2

1 reference

10 December 2017

Trent P McLaughlin

3

1 reference

10 December 2017

Jacqui Buchanan

4

1 reference

10 December 2017

Serge Gauthier

5

1 reference

10 December 2017

13 February 2013

1 reference

International Psychogeriatrics

10 December 2017

1 reference

10 December 2017

25

1 reference

10 December 2017

6

1 reference

10 December 2017

929-937

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

10 December 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1041610212002360

Cognition, function, and caregiving time patterns in patients with mild-to-moderate Alzheimer disease: a 12-month analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610212002360

Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610212002360

The disability assessment for dementia scale: a 12-month study of functional ability in mild to moderate severity Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610212002360

A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610212002360

DAD-6: A 6-ltem version of the Disability Assessment for Dementia scale which may differentiate Alzheimer's disease and mild cognitive impairment from controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610212002360

Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610212002360

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610212002360

Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610212002360

Assessment of potential measures in models of progression in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610212002360

Functional disability in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610212002360

inferred from DOI database lookup

7 January 2021

based on heuristic

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years

1 reference

https://api.crossref.org/works/10.1017%2FS1041610212002360

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1017/S1041610212002360

1 reference

10 December 2017

1 reference